Results 171 to 180 of about 10,834,348 (379)
The Development of the Feeling for Nature in the Middle Ages and Modern Times
, 1906 Alfred Biese
openalex +2 more sources
Molecular Oncology, EarlyView.This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau +9 more
wiley +1 more source
6. John Wyclif\u27s Divine Dominion and the End of the Middle Ages
, 1958 John Wyclif (c. 1320-1384) has been called both the last of the schoolmen and the morning star of the Reformation. A native Englishman and a Franciscan, he spent most of his life at the University of Oxford, first as scholar, later as teacher of theology,
Bloom, Robert L. +6 more
core
Temple symbolism in the architecture of middle ages Europe [PDF]
, 2019 Висвітлено такі акценти: християнські символи існують і для приховування істини, і для її виявлення, пізнання; пізнання вищої істини можливе лише на основі розкодування символічних образів, що втілені у середньовічному мистецтві та архітектурі, а ...
Михалевич, Віктор Вадимович
core
Molecular Oncology, EarlyView.C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald +18 more
wiley +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
Molecular Oncology, EarlyView.The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias +12 more
wiley +1 more source
Two Masters of Surgery in Parma during the Middle Ages. [PDF]
Acta Biomed, 2020 Cervellin G +3 more
europepmc +1 more source
Molecular Oncology, EarlyView.Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley +1 more source